Log in

Orthofix Medical Stock Price, News & Analysis (NASDAQ:OFIX)

$52.16
+0.41 (+0.79 %)
(As of 10/17/2019 07:00 AM ET)
Today's Range
$51.22
Now: $52.16
$52.24
50-Day Range
$49.16
MA: $51.42
$54.29
52-Week Range
$47.79
Now: $52.16
$74.44
Volume42,080 shs
Average Volume97,551 shs
Market Capitalization$994.69 million
P/E Ratio26.61
Dividend YieldN/A
Beta0.41
Orthofix Medical Inc, a medical device company, provides musculoskeletal healing products and therapies worldwide. It operates through four segments: Bone Growth Therapies, Spinal Implants, Biologics, and Orthofix Extremities. The Bone Growth Therapies segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion and are indicated as treatment to enhance fusion success rates in cervical and lumbar spine, as well as a therapeutic treatment for non-spinal appendicular fractures. Read More…

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
Current SymbolNASDAQ:OFIX
CUSIPN6748L10
Phone214-937-2000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$453.04 million
Cash Flow$3.11 per share
Book Value$18.05 per share

Profitability

Net Income$13.81 million

Miscellaneous

Employees954
Market Cap$994.69 million
Next Earnings Date11/4/2019 (Estimated)
OptionableOptionable

Receive OFIX News and Ratings via Email

Sign-up to receive the latest news and ratings for OFIX and its competitors with MarketBeat's FREE daily newsletter.


Orthofix Medical (NASDAQ:OFIX) Frequently Asked Questions

What is Orthofix Medical's stock symbol?

Orthofix Medical trades on the NASDAQ under the ticker symbol "OFIX."

How were Orthofix Medical's earnings last quarter?

Orthofix Medical Inc (NASDAQ:OFIX) posted its earnings results on Monday, August, 5th. The medical device company reported $0.28 earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of $0.40 by $0.12. The medical device company earned $115.85 million during the quarter, compared to analyst estimates of $115.17 million. Orthofix Medical had a return on equity of 9.50% and a net margin of 1.75%. The company's revenue for the quarter was up 3.9% on a year-over-year basis. During the same quarter last year, the business posted $0.42 earnings per share. View Orthofix Medical's Earnings History.

When is Orthofix Medical's next earnings date?

Orthofix Medical is scheduled to release their next quarterly earnings announcement on Monday, November 4th 2019. View Earnings Estimates for Orthofix Medical.

What guidance has Orthofix Medical issued on next quarter's earnings?

Orthofix Medical updated its FY19 earnings guidance on Monday, August, 5th. The company provided earnings per share guidance of $1.75-1.82 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.78. The company issued revenue guidance of $472-477 million, compared to the consensus revenue estimate of $473.70 million.

What price target have analysts set for OFIX?

2 brokers have issued 12-month price objectives for Orthofix Medical's shares. Their forecasts range from $60.00 to $60.00. On average, they anticipate Orthofix Medical's stock price to reach $60.00 in the next twelve months. This suggests a possible upside of 15.0% from the stock's current price. View Analyst Price Targets for Orthofix Medical.

What is the consensus analysts' recommendation for Orthofix Medical?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Orthofix Medical in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Orthofix Medical.

Has Orthofix Medical been receiving favorable news coverage?

Media headlines about OFIX stock have been trending very negative recently, according to InfoTrie Sentiment Analysis. InfoTrie identifies negative and positive media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Orthofix Medical earned a media sentiment score of -3.2 on InfoTrie's scale. They also assigned headlines about the medical device company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the near future. View News Stories for Orthofix Medical.

Are investors shorting Orthofix Medical?

Orthofix Medical saw a decline in short interest in September. As of September 30th, there was short interest totalling 409,400 shares, a decline of 12.9% from the August 30th total of 470,100 shares. Based on an average daily volume of 121,100 shares, the days-to-cover ratio is presently 3.4 days. Currently, 2.2% of the company's stock are sold short. View Orthofix Medical's Current Options Chain.

Who are some of Orthofix Medical's key competitors?

What other stocks do shareholders of Orthofix Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Orthofix Medical investors own include AbbVie (ABBV), Clovis Oncology (CLVS), Esperion Therapeutics (ESPR), Intercept Pharmaceuticals (ICPT), Madrigal Pharmaceuticals (MDGL), Zogenix (ZGNX), Allergan (AGN), Edwards Lifesciences (EW), Zoetis (ZTS) and Biogen (BIIB).

Who are Orthofix Medical's key executives?

Orthofix Medical's management team includes the folowing people:
  • Mr. Bradley R. Mason, Pres, CEO & Director (Age 65)
  • Mr. Douglas C. Rice, CFO & Chief Accounting Officer (Age 53)
  • Ms. Kimberley A. Elting, Chief Legal & Admin. Officer (Age 54)
  • Mr. Michael M. Finegan, Chief Strategy Officer (Age 55)
  • Mr. Davide Bianchi, Pres of Global Extremities (Age 54)

Who are Orthofix Medical's major shareholders?

Orthofix Medical's stock is owned by many different of institutional and retail investors. Top institutional investors include Dalton Greiner Hartman Maher & Co. (1.76%), Assenagon Asset Management S.A. (0.41%) and State of Alaska Department of Revenue (0.08%). Company insiders that own Orthofix Medical stock include Brad Mason, Bradley V Niemann, Davide Bianchi, Kimberley A Elting, Luke T Faulstick, Rice Doug and Ronald A Matricaria. View Institutional Ownership Trends for Orthofix Medical.

Which institutional investors are buying Orthofix Medical stock?

OFIX stock was bought by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., Dalton Greiner Hartman Maher & Co. and State of Alaska Department of Revenue. View Insider Buying and Selling for Orthofix Medical.

How do I buy shares of Orthofix Medical?

Shares of OFIX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Orthofix Medical's stock price today?

One share of OFIX stock can currently be purchased for approximately $52.16.

How big of a company is Orthofix Medical?

Orthofix Medical has a market capitalization of $994.69 million and generates $453.04 million in revenue each year. The medical device company earns $13.81 million in net income (profit) each year or $1.96 on an earnings per share basis. Orthofix Medical employs 954 workers across the globe.View Additional Information About Orthofix Medical.

What is Orthofix Medical's official website?

The official website for Orthofix Medical is http://www.orthofix.com/.

How can I contact Orthofix Medical?

Orthofix Medical's mailing address is 3451 Plano Parkway, Lewisville TX, 75056. The medical device company can be reached via phone at 214-937-2000 or via email at [email protected]


MarketBeat Community Rating for Orthofix Medical (NASDAQ OFIX)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  337 (Vote Outperform)
Underperform Votes:  383 (Vote Underperform)
Total Votes:  720
MarketBeat's community ratings are surveys of what our community members think about Orthofix Medical and other stocks. Vote "Outperform" if you believe OFIX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OFIX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/17/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel